Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin B Begg

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Reflections on publication criteria for genetic association studiesColin B Begg
Clinical Trials (London, England)|June 16, 2022
Evolving challenges in clinical trials designColin B Begg
Clinical Trials (London, England)|December 5, 2017
Zero tolerance for acronymsColin B Begg
Annals of Internal Medicine|February 17, 2010
Comments and response on the USPSTF recommendation on screening for breast cancerColin B Begg
Journal of Clinical Epidemiology|February 12, 2009
Meta-analysis methods for diagnostic accuracyColin B Begg
Clinical Trials (London, England)|April 30, 2021
Clinical trials in RussiaColin B Begg
JNCI Cancer Spectrum|May 7, 2020
In Defense of <i>P</i> ValuesColin B Begg
Statistics in Medicine|July 12, 2002
A comparison of methods to detect publication bias in meta-analysis by P. Macaskill, S. D. Walter and L. Irwig, Statistics in Medicine, 2001; 20:641-654Colin B Begg
Journal of the National Cancer Institute|October 11, 2013
Justifying the choice of endpoints for clinical trialsColin B Begg
Clinical Trials (London, England)|February 5, 2014
Editorial transitionColin B Begg
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Reflections on publication criteria for genetic association studiesColin B Begg
Clinical Trials (London, England)|June 16, 2022
Evolving challenges in clinical trials designColin B Begg
Clinical Trials (London, England)|December 5, 2017
Zero tolerance for acronymsColin B Begg
Annals of Internal Medicine|February 17, 2010
Comments and response on the USPSTF recommendation on screening for breast cancerColin B Begg
Journal of Clinical Epidemiology|February 12, 2009
Meta-analysis methods for diagnostic accuracyColin B Begg
Clinical Trials (London, England)|April 30, 2021
Clinical trials in RussiaColin B Begg
JNCI Cancer Spectrum|May 7, 2020
In Defense of <i>P</i> ValuesColin B Begg
Statistics in Medicine|July 12, 2002
A comparison of methods to detect publication bias in meta-analysis by P. Macaskill, S. D. Walter and L. Irwig, Statistics in Medicine, 2001; 20:641-654Colin B Begg
Journal of the National Cancer Institute|October 11, 2013
Justifying the choice of endpoints for clinical trialsColin B Begg
Clinical Trials (London, England)|February 5, 2014
Editorial transitionColin B Begg
Pageof 19